Sagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S.
Summary by abc12/WJRT
29 Articles
29 Articles

+27 Reposted by 27 other sources
Sagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S.
SCHAUMBURG, Ill., July 7, 2025 /PRNewswire/ -- Sagent Pharmaceuticals ("Sagent"), a leading provider of pharmaceuticals to the US market, and Qilu Pharmaceutical Co., Ltd. ("Qilu"), a leading vertically integrated pharmaceutical company based in China, today announced a strategic collaboration to…
·Flint, United States
Read Full ArticleSagent, Qilu partner to commercialise complex injectable products in US
Through this partnership, Sagent will gain sole rights to commercialise a select portfolio of Qilu’s complex injectable products in the US. These products encompass high-impact therapeutic areas, The post Sagent, Qilu partner to commercialise complex injectable products in US appeared first on Pharmaceutical Business review.
Coverage Details
Total News Sources29
Leaning Left1Leaning Right0Center17Last UpdatedBias Distribution94% Center
Bias Distribution
- 94% of the sources are Center
94% Center
C 94%
Factuality
To view factuality data please Upgrade to Premium